Loading…

Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation

DIAGNOSIS AND SUMMARY This patient has ethylmalonic encephalopathy (EE)3, a severe disorder affecting mitochondria and blood vessels that typically presents with central nervous system disease, gastrointestinal dysfunction, retinal vessel tortuosity, petechiae, orthostatic acrocyanosis, and the prod...

Full description

Saved in:
Bibliographic Details
Published in:Clinical chemistry (Baltimore, Md.) Md.), 2017-11, Vol.63 (11), p.1771-1773
Main Authors: Peake, Roy W A, Rodan, Lance H
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3
cites cdi_FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3
container_end_page 1773
container_issue 11
container_start_page 1771
container_title Clinical chemistry (Baltimore, Md.)
container_volume 63
creator Peake, Roy W A
Rodan, Lance H
description DIAGNOSIS AND SUMMARY This patient has ethylmalonic encephalopathy (EE)3, a severe disorder affecting mitochondria and blood vessels that typically presents with central nervous system disease, gastrointestinal dysfunction, retinal vessel tortuosity, petechiae, orthostatic acrocyanosis, and the production of ethylmalonic acid (EMA). First described in a neonate with hypotonia who subsequently developed a severe pyramidal disorder, EE was initially labeled as a branched-chain acyl-CoA dehydrogenase defect (1). [...]of butyryl-CoA dehydrogenase inhibition, there is accumulation of butyryl-CoA and isobutyryl-CoA, which conjugate with carnitine to produce butyrylcarnitine and isobutyrylcarnitine, respec- tively.
doi_str_mv 10.1373/clinchem.2017.279497
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1958542463</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1967314076</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3</originalsourceid><addsrcrecordid>eNpdkEtLAzEQgIMotlb_gciCFy9b89o8jkWqVooK6nlJs1mbms3WZBfpvzelrQeZwzAz3wzDB8AlgmNEOLnVznq9NM0YQ8THmEsq-REYooLAXBQMHYMhhFDmElE-AGcxrlJJuWCnYIAlFJJgMgRP0265cY1yrbc6m2hb9cGqzPpM-Wzma-W77Md2y-zZ9KF17afVyqVZlb19Jeg1mGh8pzrb-nNwUisXzcU-j8DH_fT97jGfvzzM7ibzXBOBurziVFMiKl4hkYKY9Ao3jFBZCVmgxWIBIWM1VlgqBWFRY05qiAustx1RkRG42d1dh_a7N7ErGxu1cU550_axRLIQBcWUkYRe_0NXbR98-i5RjBNEIWeJojtKhzbGYOpyHWyjwqZEsNy6Lg-uy63rcuc6rV3tj_eLxlR_Swe55BeGUXrT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1967314076</pqid></control><display><type>article</type><title>Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation</title><source>Oxford Journals Online</source><creator>Peake, Roy W A ; Rodan, Lance H</creator><creatorcontrib>Peake, Roy W A ; Rodan, Lance H</creatorcontrib><description>DIAGNOSIS AND SUMMARY This patient has ethylmalonic encephalopathy (EE)3, a severe disorder affecting mitochondria and blood vessels that typically presents with central nervous system disease, gastrointestinal dysfunction, retinal vessel tortuosity, petechiae, orthostatic acrocyanosis, and the production of ethylmalonic acid (EMA). First described in a neonate with hypotonia who subsequently developed a severe pyramidal disorder, EE was initially labeled as a branched-chain acyl-CoA dehydrogenase defect (1). [...]of butyryl-CoA dehydrogenase inhibition, there is accumulation of butyryl-CoA and isobutyryl-CoA, which conjugate with carnitine to produce butyrylcarnitine and isobutyrylcarnitine, respec- tively.</description><identifier>ISSN: 0009-9147</identifier><identifier>EISSN: 1530-8561</identifier><identifier>DOI: 10.1373/clinchem.2017.279497</identifier><identifier>PMID: 29089323</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Aciduria ; Brain Diseases, Metabolic, Inborn - diagnosis ; Brain Diseases, Metabolic, Inborn - genetics ; Central nervous system ; Child, Preschool ; Dehydrogenase ; Dehydrogenases ; Electroencephalography ; Female ; Humans ; Malonates - urine ; Medical screening ; Mitochondrial Proteins - genetics ; Nucleocytoplasmic Transport Proteins - genetics ; Purpura - diagnosis ; Purpura - genetics ; Skin ; Urine</subject><ispartof>Clinical chemistry (Baltimore, Md.), 2017-11, Vol.63 (11), p.1771-1773</ispartof><rights>Copyright American Association for Clinical Chemistry Nov 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3</citedby><cites>FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29089323$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peake, Roy W A</creatorcontrib><creatorcontrib>Rodan, Lance H</creatorcontrib><title>Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation</title><title>Clinical chemistry (Baltimore, Md.)</title><addtitle>Clin Chem</addtitle><description>DIAGNOSIS AND SUMMARY This patient has ethylmalonic encephalopathy (EE)3, a severe disorder affecting mitochondria and blood vessels that typically presents with central nervous system disease, gastrointestinal dysfunction, retinal vessel tortuosity, petechiae, orthostatic acrocyanosis, and the production of ethylmalonic acid (EMA). First described in a neonate with hypotonia who subsequently developed a severe pyramidal disorder, EE was initially labeled as a branched-chain acyl-CoA dehydrogenase defect (1). [...]of butyryl-CoA dehydrogenase inhibition, there is accumulation of butyryl-CoA and isobutyryl-CoA, which conjugate with carnitine to produce butyrylcarnitine and isobutyrylcarnitine, respec- tively.</description><subject>Aciduria</subject><subject>Brain Diseases, Metabolic, Inborn - diagnosis</subject><subject>Brain Diseases, Metabolic, Inborn - genetics</subject><subject>Central nervous system</subject><subject>Child, Preschool</subject><subject>Dehydrogenase</subject><subject>Dehydrogenases</subject><subject>Electroencephalography</subject><subject>Female</subject><subject>Humans</subject><subject>Malonates - urine</subject><subject>Medical screening</subject><subject>Mitochondrial Proteins - genetics</subject><subject>Nucleocytoplasmic Transport Proteins - genetics</subject><subject>Purpura - diagnosis</subject><subject>Purpura - genetics</subject><subject>Skin</subject><subject>Urine</subject><issn>0009-9147</issn><issn>1530-8561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpdkEtLAzEQgIMotlb_gciCFy9b89o8jkWqVooK6nlJs1mbms3WZBfpvzelrQeZwzAz3wzDB8AlgmNEOLnVznq9NM0YQ8THmEsq-REYooLAXBQMHYMhhFDmElE-AGcxrlJJuWCnYIAlFJJgMgRP0265cY1yrbc6m2hb9cGqzPpM-Wzma-W77Md2y-zZ9KF17afVyqVZlb19Jeg1mGh8pzrb-nNwUisXzcU-j8DH_fT97jGfvzzM7ibzXBOBurziVFMiKl4hkYKY9Ao3jFBZCVmgxWIBIWM1VlgqBWFRY05qiAustx1RkRG42d1dh_a7N7ErGxu1cU550_axRLIQBcWUkYRe_0NXbR98-i5RjBNEIWeJojtKhzbGYOpyHWyjwqZEsNy6Lg-uy63rcuc6rV3tj_eLxlR_Swe55BeGUXrT</recordid><startdate>201711</startdate><enddate>201711</enddate><creator>Peake, Roy W A</creator><creator>Rodan, Lance H</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4U-</scope><scope>7QO</scope><scope>7RV</scope><scope>7TM</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PCBAR</scope><scope>PDBOC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>201711</creationdate><title>Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation</title><author>Peake, Roy W A ; Rodan, Lance H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aciduria</topic><topic>Brain Diseases, Metabolic, Inborn - diagnosis</topic><topic>Brain Diseases, Metabolic, Inborn - genetics</topic><topic>Central nervous system</topic><topic>Child, Preschool</topic><topic>Dehydrogenase</topic><topic>Dehydrogenases</topic><topic>Electroencephalography</topic><topic>Female</topic><topic>Humans</topic><topic>Malonates - urine</topic><topic>Medical screening</topic><topic>Mitochondrial Proteins - genetics</topic><topic>Nucleocytoplasmic Transport Proteins - genetics</topic><topic>Purpura - diagnosis</topic><topic>Purpura - genetics</topic><topic>Skin</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peake, Roy W A</creatorcontrib><creatorcontrib>Rodan, Lance H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Earth, Atmospheric &amp; Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>https://resources.nclive.org/materials</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Earth, Atmospheric &amp; Aquatic Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peake, Roy W A</au><au>Rodan, Lance H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation</atitle><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle><addtitle>Clin Chem</addtitle><date>2017-11</date><risdate>2017</risdate><volume>63</volume><issue>11</issue><spage>1771</spage><epage>1773</epage><pages>1771-1773</pages><issn>0009-9147</issn><eissn>1530-8561</eissn><abstract>DIAGNOSIS AND SUMMARY This patient has ethylmalonic encephalopathy (EE)3, a severe disorder affecting mitochondria and blood vessels that typically presents with central nervous system disease, gastrointestinal dysfunction, retinal vessel tortuosity, petechiae, orthostatic acrocyanosis, and the production of ethylmalonic acid (EMA). First described in a neonate with hypotonia who subsequently developed a severe pyramidal disorder, EE was initially labeled as a branched-chain acyl-CoA dehydrogenase defect (1). [...]of butyryl-CoA dehydrogenase inhibition, there is accumulation of butyryl-CoA and isobutyryl-CoA, which conjugate with carnitine to produce butyrylcarnitine and isobutyrylcarnitine, respec- tively.</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>29089323</pmid><doi>10.1373/clinchem.2017.279497</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-9147
ispartof Clinical chemistry (Baltimore, Md.), 2017-11, Vol.63 (11), p.1771-1773
issn 0009-9147
1530-8561
language eng
recordid cdi_proquest_miscellaneous_1958542463
source Oxford Journals Online
subjects Aciduria
Brain Diseases, Metabolic, Inborn - diagnosis
Brain Diseases, Metabolic, Inborn - genetics
Central nervous system
Child, Preschool
Dehydrogenase
Dehydrogenases
Electroencephalography
Female
Humans
Malonates - urine
Medical screening
Mitochondrial Proteins - genetics
Nucleocytoplasmic Transport Proteins - genetics
Purpura - diagnosis
Purpura - genetics
Skin
Urine
title Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A32%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ethylmalonic%20Aciduria%20in%20an%20Infant%20with%20Neurological%20and%20Skin%20Presentation&rft.jtitle=Clinical%20chemistry%20(Baltimore,%20Md.)&rft.au=Peake,%20Roy%20W%20A&rft.date=2017-11&rft.volume=63&rft.issue=11&rft.spage=1771&rft.epage=1773&rft.pages=1771-1773&rft.issn=0009-9147&rft.eissn=1530-8561&rft_id=info:doi/10.1373/clinchem.2017.279497&rft_dat=%3Cproquest_cross%3E1967314076%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c381t-d74c438d7d181813e0897e6349d8951bbb0066f2a29aa005f273f0252ca29a8d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1967314076&rft_id=info:pmid/29089323&rfr_iscdi=true